Stock AnalizCooper Companies, Inc. COO
Ophthalmic Goods · data as of November 13, 2026
Cooper Companies, Inc. (COO) is a healthcare company listed in the US with a market value of about $11.9B. In the twelve months to July 31, 2026 it had revenue of $4.2B and net income of $570M, a net margin of 13.5%.
Its overall Stock Analiz score is 2.4 out of 5 (weak). The strongest part is financial health (4/5); the weakest is future growth (1/5).
Key numbers: a P/E of 21.5, a price to free cash flow of 17.6, 5-year revenue growth of 11% a year, a 5-year average ROIC of 4%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 38% below the current price.
Score: 2.4 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Profit margin improving
- 5-year revenue growth above 8% a year
- Profitable 5 years in a row
- More cash than debt, or low debt to equity
- Positive free cash flow
Checks not passed
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.2B | $4.1B | $3.9B | $3.6B | $3.3B | $2.9B | $2.4B | $2.7B | $2.5B | $2.1B | $2.0B |
| Net income | $570M | $375M | $392M | $294M | $386M | $2.9B | $238M | $467M | $140M | $373M | $274M |
| Free cash flow | $678M | $434M | $288M | $215M | $450M | $524M | $176M | $421M | $475M | $466M | $357M |
| EPS (diluted) | $2.92 | $1.87 | $1.96 | $1.48 | $1.94 | $14.79 | $1.20 | $2.33 | $0.70 | $1.88 | $1.40 |
| Net margin | 13.5% | 9.2% | 10.1% | 8.2% | 11.7% | 100.8% | 9.8% | 17.6% | 5.5% | 17.4% | 13.9% |
| ROIC | — | 4.1% | 4.3% | 3.7% | 4.0% | 4.6% | 4.7% | 9.8% | 6.0% | 9.3% | 7.5% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 15 analysts is $65.80, 5% above the current price; targets range from $58.00 to $75.00; the consensus rating is “Hold”; expected EPS is $4.53 for the fiscal year ending October 31, 2026.
Frequently asked questions
What is Cooper Companies’s P/E ratio?
About 21.5, based on the last twelve months of diluted earnings per share (forward P/E about 13.9).
Is Cooper Companies stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 38% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Cooper Companies pay a dividend?
Not currently.
Is Cooper Companies a good stock to buy?
We do not give buy or sell advice. Cooper Companies scores 2.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.